News

NEWS

10/27/22 Akorn Introduces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg at ASRM
08/16/22 Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
03/09/22 Akorn Announces Completion of the Sale of its Branded Ophthalmic Products to Théa Pharma
05/27/21 Akorn Announces Agreement to Sell its Consumer Health Business to Prestige Consumer Healthcare
05/10/21 Akorn Announces Two Key Executive Appointments

Events Events

Date Title Download
No upcoming events scheduled. Please check back.

Annual Reports Media Contact

Please direct all media inquiries to media@akorn.com

media@akorn.com